Analysis of availability and usage of current treatments for cutaneous T-cell lymphoma in Canada

Background: Canadian analyses from the last few decades have shown that the incidence of CTCL has been increasing until 1998 and then it has stabilized at the rate of ∼11-12 cases per million individuals per year. Furthermore, our recent comprehensive investigations on CTCL epidemiology in Canada have documented a nonrandom distribution of this cancer in Canada with higher CTCL incidences being detected in Newfoundland and Labrador, Maritime, and Prairie provin ces. Geographic CTCL clustering of cases was observed in a number of specific industrial communities throughout Canada.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Source Type: research